# Botox for Treatment of TMJ Disorder With Bruxism

> **NCT02202070** · PHASE1 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- Temporomandibular Joint Disorders
- Bruxism
- Temporomandibular Joint Dysfunction Syndrome
- Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint

## Interventions

- **DRUG:** onabotulinumtoxinA

## Key facts

- **NCT ID:** NCT02202070
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02202070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02202070, "Botox for Treatment of TMJ Disorder With Bruxism". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02202070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*